HealthBeacon SHA

Regulatory Filings • Jan 27, 2022

National Storage Mechanism | Additional information

RNS Number : 7642Z

HealthBeacon PLC

27 January 2022

27 January 2022

HealthBeacon Places Build Order for 35,000 Smart Sharps Bin Units

HealthBeacon plc ("HealthBeacon" or the "Company"), the leading digital therapeutics company that develops products for managing injectable medications for patients in the home, is pleased to announce it has, this month, placed a build order for 35,000 Smart Sharps Bin units to meet anticipated demand during 2022 from pharmaceutical clients, specialty pharmacy and its newly launched direct-to-consumer ("DTC") website.

The Company has a near-term target of 100,000 patients using its Injection Care Management System, representing an approximately ten-fold increase on the numbers units deployed by HealthBeacon at the end of 2021.

HealthBeacon has commenced pre-orders for online distribution through its new DTC website in partnership with Hamilton Beach and it expected that the Company's Smart Sharps Bin will also be available to North American consumers through the digital assets of some of the major leading retail and pharmacy chains in the U.S. during the first half of this year.

Jim Joyce, CEO, and co-founder of HealthBeacon said: "I'm very encouraged by the progress we have been making at HealthBeacon, and in particular, the demand we are anticipating throughout 2022 across our distribution channels. Placing a build order for 35,000 Smart Sharps Bin units for deployment during 2022 demonstrates strong momentum towards what we expect will be a ten-fold increase in the number of patients using our injection care management system by the end of next year. At HealthBeacon, our fundamental aim is to make our product globally accessible to the tens of millions of patients worldwide that are managing injectable medications in the home."

HealthBeacon will release its financial results for the year ended 31 December 2021 on Wednesday 30 March 2022.

Enquiries:
HealthBeacon: Laurence Flavin	Investor.Relations@HealthBeacon.com
Goodbody (Euronext Growth Adviser and Broker): David Kearney	+353 (1) 667 0420
Stephen Kane
Drury (Public Relations):
Billy Murphy	+353 (0) 87 231 3085
Cathal Barry	+353 (0) 87 227 9281

Ends

About HealthBeacon

Headquartered in Dublin, HealthBeacon is an Irish digital therapeutics company that develops products for managing injectable medications for patients in the home. The HealthBeacon Injection Care Management System tracks adherence and persistence with medication schedules through the provision of medication management reminders, safe and sustainable sharps disposal devices, educational tools, and artificial intelligence (AI) driven data analytics. The Company operates in 17 countries primarily across Europe, North America and the United Kingdom employs more than 50 people and has obtained more than 30 design and utility patents. Peer reviewed evidence supports a 19% improvement in therapy persistence by patients, which improves clinical outcomes and significantly improves efficiency in health systems. The Company's mission is to become the world's leading digital therapeutics platform for injectable medications. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEBFMRTMTITBTT